KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Pension (2017 - 2025)

Novartis Ag's Pension history spans 9 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Pension rose 4.07% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, up 4.07%, while the annual FY2025 figure was $1.6 billion, 4.07% up from the prior year.
  • Pension for Q4 2025 was $1.6 billion at Novartis Ag, up from $1.6 billion in the prior quarter.
  • Across five years, Pension topped out at $2.6 billion in Q4 2021 and bottomed at $1.6 billion in Q4 2024.
  • The 5-year median for Pension is $1.7 billion (2022), against an average of $1.9 billion.
  • The largest annual shift saw Pension crashed 34.73% in 2022 before it increased 5.34% in 2023.
  • A 5-year view of Pension shows it stood at $2.6 billion in 2021, then plummeted by 34.73% to $1.7 billion in 2022, then grew by 5.34% to $1.8 billion in 2023, then decreased by 13.44% to $1.6 billion in 2024, then rose by 4.07% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for NVS's Pension are $1.6 billion (Q4 2025), $1.6 billion (Q4 2024), and $1.8 billion (Q4 2023).